News Daily News ESC Heart Failure 2022 SERENADE: No Benefit, Possible Harm With Macitentan in HFpEF and PAH Shelley Wood May 22, 2022
News Daily News RELAX-AHF-2: Lack of Benefit With Serelaxin in Acute HF Still a Puzzle for Investigators L.A. McKeown August 21, 2019
News Daily News Un Comité Asesor de la FDA No Avala la Afirmación de que Ezetimibe Reduce los Episodios CV Michael O'Riordan December 15, 2015
News Daily News Ezetimibe Fails to Garner Support for CV- Event Reduction Claim From FDA Advisory Committee Michael O'Riordan December 15, 2015